» Articles » PMID: 35008419

RhoGDI2-Mediated Rac1 Recruitment to Filamin A Enhances Rac1 Activity and Promotes Invasive Abilities of Gastric Cancer Cells

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Jan 11
PMID 35008419
Authors
Affiliations
Soon will be listed here.
Abstract

Rho GDP dissociation inhibitor 2 (RhoGDI2), a regulator of Rho family GTPase, has been known to promote tumor growth and malignant progression in gastric cancer. We previously showed that RhoGDI2 positively regulates Rac1 activity and Rac1 activation is critical for RhoGDI2-induced gastric cancer cell invasion. In this study, to identify the precise molecular mechanism by which RhoGDI2 activates Rac1 activity, we performed two-hybrid screenings using yeast and found that RhoGDI2 plays an important role in the interaction between Rac1, Filamin A and Rac1 activation in gastric cancer cells. Moreover, we found that Filamin A is required for Rac1 activation and the invasive ability of gastric cancer cells. Depletion of Filamin A expression markedly reduced Rac1 activity in RhoGDI2-expressing gastric cancer cells. The migration and invasion ability of RhoGDI2-expressing gastric cancer cells also substantially decreased when Filamin A expression was depleted. Furthermore, we found that Trio, a Rac1-specific guanine nucleotide exchange factor (GEF), is critical for Rac1 activation and the invasive ability of gastric cancer cells. Therefore, we conclude that RhoGDI2 increases Rac1 activity by recruiting Rac1 to Filamin A and enhancing the interaction between Rac1 and Trio, which is critical for the invasive ability of gastric cancer cells.

Citing Articles

Correlation analysis of serum Rac1 level with asthma control, airway inflammatory response and lung function in asthmatic children.

Fu H, Gao Y BMC Pulm Med. 2024; 24(1):455.

PMID: 39285415 PMC: 11406832. DOI: 10.1186/s12890-024-03266-5.


Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions.

Matsuoka T, Yashiro M Cancers (Basel). 2024; 16(1).

PMID: 38201481 PMC: 10778111. DOI: 10.3390/cancers16010054.


Dahuang-Taoren, a botanical drug combination, ameliorates adenomyosis inhibiting Rho GTPases.

Lei Y, Fu X, Chen M, Yi Y, Mao P, Peng L Front Pharmacol. 2023; 14:1089004.

PMID: 36969843 PMC: 10035534. DOI: 10.3389/fphar.2023.1089004.


The Dual Function of RhoGDI2 in Immunity and Cancer.

Tripathi M, Colige A, Deroanne C Int J Mol Sci. 2023; 24(4).

PMID: 36835422 PMC: 9960019. DOI: 10.3390/ijms24044015.


Deficiency of filamin A in smooth muscle cells protects against hypoxia‑mediated pulmonary hypertension in mice.

Zheng Y, Ma H, Yan Y, Ye P, Yu W, Lin S Int J Mol Med. 2023; 51(3).

PMID: 36704846 PMC: 9911089. DOI: 10.3892/ijmm.2023.5225.


References
1.
Cho H, Kim I, Park S, Baek K, Nam I, Park S . VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Int J Cancer. 2014; 135(7):1553-63. DOI: 10.1002/ijc.28801. View

2.
van der Flier A, Sonnenberg A . Structural and functional aspects of filamins. Biochim Biophys Acta. 2001; 1538(2-3):99-117. DOI: 10.1016/s0167-4889(01)00072-6. View

3.
Ma L, Xu G, Sotnikova A, Szczepanowski M, Giefing M, Krause K . Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol. 2007; 139(2):217-23. DOI: 10.1111/j.1365-2141.2007.06782.x. View

4.
Parri M, Chiarugi P . Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal. 2010; 8:23. PMC: 2941746. DOI: 10.1186/1478-811X-8-23. View

5.
Himmel M, van der Ven P, Stocklein W, Furst D . The limits of promiscuity: isoform-specific dimerization of filamins. Biochemistry. 2003; 42(2):430-9. DOI: 10.1021/bi026501+. View